主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ACRS
#2714
Aclaris Therapeutics, Inc.
2.8
7
-8.01%
版块:
基础:
利润货币:
日范围
年范围
日变化
-8.01%
每月变动
-26.41%
6个月变化
+56.83%
年变化
+50.26%
前一天收盘价
3.1
2
Open
2.8
7
Bid
Ask
Low
2.8
7
High
2.8
7
交易量
58
市场
股票
医疗保健
ACRS
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Dividends per share
—
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
—
新闻
Stifel因管线前景上调Aclaris Therapeutics目标价至3美元
Stifel raises Aclaris Therapeutics stock price target to $3 on pipeline
Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates
Aclaris TherapeuticsQ4每股收益及营收逊于预期
Aclaris Therapeutics Inc earnings missed by $0.01, revenue fell short of estimates
Ionis Pharmaceuticals (IONS) Reports Q4 Loss, Tops Revenue Estimates
Corcept Therapeutics (CORT) Q4 Earnings and Revenues Miss Estimates
Aclaris启动ATI-052治疗哮喘患者的1b期试验
Aclaris starts phase 1b trial of ATI-052 in asthma patients
Craig-Hallum 以"买入"评级开始对 Aclaris Therapeutics 股票的覆盖
Craig-Hallum initiates coverage on Aclaris Therapeutics stock with Buy rating
Aclaris stock gets Buy rating reaffirmed by H.C. Wainwright after positive preclinical results